百特
22.75
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About 百特
Baxter International Inc. 通過其子公司在全球範圍內開發和提供一系列保健產品。公司提供腹膜透析和血液透析，以及其他透析治療和服務；靜脈療法、輸液泵、給藥裝置和藥物重構裝置；混合和腫瘤藥物平台、吸入麻醉和重症監護產品以及藥物混合服務；腸外營養療法及相關產品；外科手術中用於止血、組織封閉和防粘連的生物製品和醫療器械；持續的腎臟替代療法和重症監護病房的其他器官支持療法。它還提供互聯護理解決方案，包括設備、軟件、通信和集成技術；集成患者監測和診斷技術，以幫助診斷、治療和管理各種疾病，包括呼吸治療、心髒病學、視力篩查和身體評估；手術視頻技術、桌子、燈、吊墜、精確定位裝置和其他配件。此外，該公司還為各種製藥和生物製藥公司提供合同服務。其產品用於醫院、腎透析中心、療養院、康復中心、醫生辦公室以及在醫生監督下在家中的患者。該公司通過直接銷售人員以及獨立分銷商、藥品批發商和專業藥房或其他替代地點供應商在大約 100 個國家/地區銷售其產品。它與 Celerity Pharmaceutical, LLC 達成協議，開發急性護理仿製藥可注射預混劑和溶瘤分子。 Baxter International Inc. 成立於 1931 年，總部位於伊利諾伊州迪爾菲爾德。
Trade GPT
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.